GLP-1 therapy supports sustainable weight loss by improving appetite control, metabolic balance, and insulin sensitivity. This medically guided approach helps reduce cravings and support steady fat loss without extreme dieting, making it an effective option for long-term metabolic wellness.
GLP-1 (glucagon-like peptide-1) is a natural hormone involved in appetite control, digestion, and blood sugar regulation. When GLP-1 signaling is impaired, it can contribute to increased hunger, cravings, blood sugar instability, and difficulty losing weight—even with healthy habits. GLP-1 therapy works by mimicking this hormone to help reduce appetite, slow digestion, and improve insulin sensitivity, supporting gradual, sustainable fat loss without extreme dieting.
At SanaVita, GLP-1 therapy is part of a structured, evidence-based approach to metabolic health. Care begins with a review of your health history, goals, and lab work, followed by ongoing monitoring and lifestyle support to ensure treatment is safe, effective, and aligned with long-term wellness—not short-term fixes.
GLP-1 therapy helps regulate hunger signals, making it easier to feel satisfied with smaller portions and reduce persistent cravings.
By supporting appetite regulation and metabolic balance, GLP-1 therapy encourages gradual fat loss without extreme dieting or excessive exercise.
Reduced Cravings & Emotional Eating
Many individuals experience fewer food cravings and improved control over emotional or stress-related eating patterns.
GLP-1 therapy helps address metabolic slowdown, supporting healthier body composition and long-term weight maintenance when combined with lifestyle changes.
Sustainable weight loss through metabolic and appetite regulation.
GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a naturally occurring hormone involved in blood sugar regulation, digestion, and appetite control. These therapies are used in metabolic optimization programs to help reduce cravings, improve insulin sensitivity, and support steady, sustainable fat loss.
By slowing stomach emptying and enhancing satiety, GLP-1 therapy can help lower overall calorie intake without extreme dieting or excessive exercise. This option may be appropriate for men and women who struggle with appetite control, metabolic slowdown, or weight maintenance despite healthy habits. Your provider will review your goals, medical history, and lab work to determine whether GLP-1 therapy is a good fit within your broader wellness plan.
GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural hormone in the body that helps regulate blood sugar, digestion, and appetite. They are used in wellness and metabolic optimization programs to improve energy balance, reduce cravings, and support sustainable fat loss.
Men and women who:
Your provider will review your goals, medical history, and lab work to determine if GLP-1 therapy is appropriate for you.
Administered as a once-weekly subcutaneous injection (under the skin). The dose is gradually increased over several weeks to improve tolerance and minimize side effects.
These symptoms typically improve as your body adjusts to the medication.
Yes, some patients experience temporary hair shedding. This can occur from:
Hair regrowth generally occurs once weight and nutrition stabilize. Adequate protein, hydration, and micronutrient support help minimize shedding.
Most patients notice appetite suppression within 1–2 weeks and visible body-composition changes within 4–8 weeks.
Optimal results are achieved after 3–6 months, depending on dose titration and individual response.
Appetite may increase and some weight regain can occur. Continuing a nutrient-dense diet, exercise routine, and good sleep hygiene helps maintain results.
Not usually. GLP-1s do not cause hypoglycemia unless used with insulin or other glucose-lowering medications.
Alcohol should be avoided. GLP-1 medications slow stomach emptying, which can amplify alcohol’s effects and increase nausea, vomiting, or hypoglycemia risk. Alcohol also counteracts metabolic improvements and can strain the liver during active weight loss.
Yes, many patients safely use GLP-1s alongside thyroid medication or HRT. However, individuals with a personal or family history of medullary thyroid carcinoma (MTC) or MEN-2 should not use GLP-1s.
You’ll need baseline labs before starting, repeat labs in 3 months, and then every 6–12 months thereafter to monitor progress and ensure safe, effective treatment.
Yes—GLP-1s work best when combined with:
These habits preserve lean muscle, optimize metabolism, and reduce side effects like fatigue or hair loss.
Yes. GLP-1s should be stopped at least 2 months before trying to conceive and are not recommended during pregnancy or breastfeeding.
Both are highly effective GLP-1–based medications used for weight management and metabolic health, but they work slightly differently:
Both medications are injected once weekly and are titrated gradually to reduce side effects. The “best” option depends on your tolerance, goals, and provider’s recommendation.
